Chemed (CHE) Valuation Reassessed After Earnings Miss And Softer 2026 Guidance [Yahoo! Finance]
Chemed Q4 Earnings Call Highlights [Yahoo! Finance]
Chemed (CHE) had its price target lowered by Oppenheimer Holdings, Inc. from $580.00 to $500.00. They now have an "outperform" rating on the stock.
Chemed (CHE) had its "sector perform" rating reaffirmed by Royal Bank Of Canada. They now have a $422.00 price target on the stock.
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses